Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CanXida Remove
- Development stage
- Unknown
- Lead developer
- CanXida
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
CanXida Remove is a multi-ingredient dietary supplement formulated to address *Candida albicans* overgrowth and other systemic or localized fungal infections. Developed by CanXida Health, the product features a synergistic blend of standardized herbal extracts, fatty acids, and nutrients known for their antifungal, antibacterial, and antiparasitic properties. The formula typically includes caprylic acid, undecylenic acid, berberine, garlic extract (allicin), grapefruit seed extract, black walnut hull, pau d'arco, neem, and oregano oil. These constituents work through multiple mechanisms, including the disruption of fungal cell membranes and the inhibition of yeast-to-hyphae transition, which is critical for Candida pathogenicity. It is often utilized as a core component of a comprehensive "Candida cleanse" protocol to restore gut microbiome balance.
- Brand names
- CanXida Remove
- Other names
- CanXida Remove Candida Cleansing FormulaCanXida Remove Antifungal Supplement
Beyond the preview
Go deeper on CanXida Remove.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CanXida Remove.